Mark S. Hixon

Also affiliated with Johnson & Johnson (Israel)

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay”.

Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assay

Bioorganic & Medicinal Chemistry(2021)10.1016/j.bmc.2021.116246

N/A

0DataRank · unranked

8 citations

Jonathan R. Hart, BanuPriya Sridharan, Scott J. Novick, Lewis D. Turner, Bin Zhou +11 more

Targeted Reversible Covalent Modification of a Noncatalytic Lysine of the Krev Interaction Trapped 1 Protein Enables Site-Directed Screening for Protein–Protein Interaction Inhibitors

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00156

N/A

0DataRank · unranked

11 citations

Jessica Bruystens, Carmine Varricchio, Sara McCurdy, Jian Wu, Miguel Alejandro Lopez‐Ramirez +7 more

PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement

Neuropsychopharmacology(2024)10.1038/s41386-024-01951-x

N/A

0DataRank · unranked

3 citations

Ganesh B. Chand, Nicole Caito, Anna Eramo, V. Grattan, Mark S. Hixon +10 more